Skip to main content
OpenTrials

Clinical trial condition

Relapsed or Refractory Acute Lymphoblastic Leukemia

Explore clinical trials studying Relapsed or Refractory Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed or Refractory Acute Lymphoblastic Leukemia trial results

Recruiting

Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT04684147

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Beijing Boren Hospital Beijing, Beijing Municipality, China
  • Xinqiao Hospital of TMMU Chongqing, Chongqing Municipality, China
  • Nanfang Hospital Guangzhou, Guangdong, China
  • Yanda hospital, Hebei medical university Sanhe, Hebei, China
View Trial Details

Related conditions